MITF and melanoma: Confirmatory immunostaining was demonstrating immunoreactivity for some or all of melanoma markers, such as S100, HMB-45, Melan-A and micropthalmia transcription factor (MITF), can be used to aid the diagnosis of metastatic melanoma [19].